Literature DB >> 7959570

Classification and surgical treatment of hepatocellular carcinoma (HCC) with bile duct thrombi.

M Ueda1, T Takeuchi, T Takayasu, K Takahashi, S Okamoto, A Tanaka, T Morimoto, K Mori, Y Yamaoka.   

Abstract

Nine (1.66%) out of 542 cases of HCC treated surgically in our hospital between 1985 and 1992, had macroscopic bile duct thrombi. Three cases presented preoperatively with obstructive jaundice. Two of these received thrombectomy in the hilar bile duct and died of hepatic insufficiency on postoperative days 10 and 66, the other case underwent extended left lobectomy, but also died of renal failure and sepsis 3 months after the operation. In addition, we also treated 6 cases diagnosed at earlier stages than those presenting with obstructive jaundice with both hepatectomy and thrombectomy. In these patients the outcome was as follows: 2 died of recurrent HCC 3 months and 16 months, respectively, after operation, 1 died of apoplexy with no recurrence after 19 months, 1 had a recurrence 5 months after the operation, but is still alive after 7 months, and 2 are still alive 24 months and 60 months after surgery with no recurrence. The outcome is still poor in our series with obstructive jaundice. But in this report, we propose radical surgical treatment for HCC with bile duct thrombi in accordance with our classification, especially for those cases without obstructive jaundice.

Entities:  

Mesh:

Year:  1994        PMID: 7959570

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  30 in total

1.  An icteric type hepatocellular carcinoma with no detectable tumor in the liver: report of a case.

Authors:  Tomoki Makino; Shoji Nakamori; Masaki Kashiwazaki; Norikazu Masuda; Masakazu Ikenaga; Motohiro Hirao; Kazumasa Fujitani; Hideyuki Mishima; Toshiro Sawamura; Masashi Takeda; Masayuki Mano; Toshimasa Tsujinaka
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  Bile duct thrombi in hepatocellular carcinoma: is aggressive surgery worthwhile?

Authors:  Ashwin Rammohan; Jeswanth Sathyanesan; Kamalakannan Rajendran; Anbalagan Pitchaimuthu; Senthil K Perumal; Kesavan Balaraman; Ravi Ramasamy; Ravichandran Palaniappan; Manoharan Govindan
Journal:  HPB (Oxford)       Date:  2015-01-09       Impact factor: 3.647

3.  Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus.

Authors:  Tiffany C L Wong; Tan To Cheung; Kenneth S H Chok; Albert C Y Chan; Wing Chiu Dai; See Ching Chan; Ronnie T P Poon; Sheung Tat Fan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2014-11-19       Impact factor: 3.647

4.  Intrahepatic bile duct recurrence of hepatocellular carcinoma without a detectable liver tumor.

Authors:  Tomoyuki Abe; Kiyoshi Kajiyama; Norifumi Harimoto; Tomonobu Gion; Ken Shirabe; Takashi Nagaie
Journal:  Int J Surg Case Rep       Date:  2012-03-28

5.  Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi.

Authors:  Chun-Nan Yeh; Yi-Yin Jan; Wei-Chen Lee; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

6.  Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients.

Authors:  Lun-Xiu Qin; Zeng-Chen Ma; Zhi-Quan Wu; Jia Fan; Xin-Da Zhou; Hui-Chuan Sun; Qing-Hai Ye; Lu Wang; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

7.  Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma.

Authors:  Shu You Peng; Jian Wei Wang; Ying Bin Liu; Xiu Jun Cai; Gui Long Deng; Bin Xu; Hai Jun Li
Journal:  World J Surg       Date:  2003-11-26       Impact factor: 3.352

8.  Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities.

Authors:  Luo Xiangji; Tan Weifeng; Yi Bin; Liu Chen; Jiang Xiaoqing; Zhang Baihe; Shen Feng; Wu Mengchao
Journal:  Langenbecks Arch Surg       Date:  2009-05-07       Impact factor: 3.445

Review 9.  Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus.

Authors:  Suresh Navadgi; Chi-Chun Chang; Adam Bartlett; John McCall; Sanjay Pandanaboyana
Journal:  HPB (Oxford)       Date:  2016-02-18       Impact factor: 3.647

Review 10.  Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.